Related Experiment Videos
Cerebrospinal fluid beta-2-microglobulin in multiple sclerosis and AIDS dementia complex
P B Carrieri1, A Indaco, A Maiorino
1Institute of Neurology, 2nd Medical School, University of Naples, Italy.
Neurological Research
|June 1, 1992
Summary
Cerebrospinal fluid beta-2-microglobulin (beta-2-m) levels can help diagnose AIDS dementia complex (ADC). In multiple sclerosis (MS) patients, CSF beta-2-m levels are not a valuable diagnostic marker.
Area of Science:
- Neurology
- Immunology
- Biochemistry
Background:
- Beta-2-microglobulin (beta-2-m) is a protein found in serum and cerebrospinal fluid (CSF).
- Elevated CSF beta-2-m levels have been observed in various neurological conditions.
- Distinguishing between neurological diseases like multiple sclerosis (MS) and AIDS dementia complex (ADC) is clinically important.
Purpose of the Study:
- To investigate the diagnostic utility of CSF and serum beta-2-m concentrations in differentiating MS and ADC.
- To compare beta-2-m levels in patients with ADC, MS, and other neurological diseases (OND).
Main Methods:
- Quantified CSF and serum beta-2-m levels in 19 MS patients, 21 ADC patients, and 20 OND subjects.
- Analyzed CSF beta-2-m concentrations and the CSF/serum beta-2-m ratio.
Main Results:
- CSF beta-2-m and the CSF/serum beta-2-m ratio were significantly elevated in ADC patients compared to MS and OND patients.
- No significant difference in CSF and serum beta-2-m levels was found between MS and OND patients.
- CSF beta-2-m levels showed no diagnostic value in distinguishing MS from OND.
Conclusions:
- CSF beta-2-m and CSF/serum ratio serve as potential biomarkers for diagnosing AIDS dementia complex.
- Beta-2-microglobulin measurements in CSF are not clinically useful for diagnosing multiple sclerosis.